Cover Image

Tenofovir and its potential in the treatment of hepatitis B virus

Laura Reynaud, Maria Aurora Carleo, Maria Talamo, Guglielmo BorgiaDepartment of Public Medicine and Social Security – Section of Infectious Disease University of Naples “Federico II”, ItalyAbstract: Recent literature is reviewed about treatment of chronic hepatitis B vi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura Reynaud (Author), Maria Aurora Carleo (Author), Maria Talamo (Author), Guglielmo Borgia (Author)
Format:	Book
Published:	Dove Medical Press, 2009-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series
by: Behrooz Ataei, et al.
Published: (2016)

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy
by: Ogawa E, et al.
Published: (2017)

Vertical transmission of hepatitis B virus: challenges and solutions
by: Gentile I, et al.
Published: (2014)

Non-Inferior Efficacy of Tenofovir Disoproxil to Tenofovir Disoproxil Fumarate in Virologically Suppressed Chronic Hepatitis B Patients
by: Yim HJ, et al.
Published: (2022)

Effectiveness and safety of tenofovir amibufenamide and its comparison with tenofovir alafenamide in patients with chronic hepatitis B: results from a retrospective real-world study
by: Lanqing Li, et al.
Published: (2023)

Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa
by: Jolynne Mokaya, et al.
Published: (2019)

Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
by: Emmanouil Sinakos, et al.
Published: (2024)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016)

Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study
by: Yu-Han Huang, et al.
Published: (2023)

Virologic breakthrough in a patient with chronic hepatitis B by combination treatment with tenofovir disoproxil fumarate and entecavir
by: Suzuki F, et al.
Published: (2014)

Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature review
by: Iulia Baciu, et al.
Published: (2021)

Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a reconstructed individual patient data meta-analysis
by: Jian-Xin Peng, et al.
Published: (2024)

Resultados en la práctica clínica del tratamiento de la hepatitis crónica por virus B con tenofovir y entecavir
by: Diana Horta, et al.

Efficacy of Tenofovir Disoproxil Fumarate in Preventing Vertical Transmission of Hepatitis B in Mothers with Chronic Hepatitis B: An Evidence-Based Case Report
by: Ris Raihan Felim, et al.
Published: (2024)

Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females
by: Tan DHS
Published: (2012)

Clinical study of ganshuang granule combined with tenofovir in the treatment of chronic hepatitis B complicated with nonalcoholic fatty liver disease
by: Changtian Su, et al.
Published: (2022)

Long-Term Effects of Tenofovir on Liver Histopathology in Patients with Chronic Viral Hepatitis B Infection
by: Bengü TATAR, et al.
Published: (2020)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005)

A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection
by: Lingbo Hu, et al.
Published: (2024)

Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
by: Aida N. Kawuma, et al.
Published: (2023)

Tough choices: Tenofovir, tenders and treatment
by: Nathan Ford, et al.
Published: (2008)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy
by: Teerha Piratvisuth, et al.
Published: (2016)

A severe case of tenofovir-associated acute kidney injury requiring hemodialysis in a patient with chronic hepatitis B
by: A Young Cho, et al.
Published: (2020)

High prevalence of hepatitis B virus susceptibility among persons undergoing community-based hepatitis C virus treatment
by: Catherine Campusano, et al.
Published: (2024)

Urine Assay to Measure Tenofovir Concentrations in Patients Taking Tenofovir Alafenamide
by: Linden Lalley-Chareczko, et al.
Published: (2020)

Hepatitis B Virus Reactivation Following Treatment of HNSCC With Cisplatin
by: James Crosby DO, et al.
Published: (2022)

Linking the Population Pharmacokinetics of Tenofovir and Its Metabolites With Its Cellular Uptake and Metabolism
by: K Madrasi, et al.
Published: (2014)

Real-world impact of switching from tenofovir disoproxil fumarate to tenofovir alafenamide
by: Sarah M Michienzi, et al.
Published: (2021)

Hepatitis B Virus Immunization Today
by: Stanley A. Gall
Published: (2001)

Educational Case: Hepatitis B Virus
by: Caitlin M. Nickens MD, et al.
Published: (2019)

Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016)

Epidemiology of hepatitis B virus infection in the Republic of Moldova
by: Petru Iarovoi, Constantin Rimis, Constantin Spinu, Maria Isac
Published: (2008)

Pre-Clinical Evaluation of Tenofovir and Tenofovir Alafenamide for HIV-1 Pre-Exposure Prophylaxis in Foreskin Tissue
by: Laura Else, et al.
Published: (2022)

Tenofovir induced acute kidney injury and its outcome; an Indian perspective
by: Sreedhara C. Gurusiddaiah, et al.
Published: (2023)

Hepatitis C and hepatitis B virus infections in the etiopathogenesis of pemphigus
by: Gulsen Tukenmez Demirci, et al.
Published: (2014)

Hepatitis delta in patients with resolved hepatitis B virus infection
by: Antonio Aguilera, et al.
Published: (2018)

The in vitro and in vivo anti-hepatotoxic, anti-hepatitis B virus and hepatic CYP450 modulating potential of Cyperus rotundus
by: Mohammad K. Parvez, et al.
Published: (2019)

Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?
by: Andrew Hill, et al.
Published: (2018)

Distribution Evaluation of Tenofovir in the Breast Milk of Mothers With HBeAg-Positive Chronic HBV Infection After Treatment With Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate by a Sensitive UPLC-MS/MS Method
by: Na Yang, et al.
Published: (2021)

Prevalence of Human Immunodeficiency Virus, Hepatitis B and Hepatitis C Virus Antibodies and Hepatitis B Antigen Among Commercial Sex Workers in Japan
by: Kazuhisa Ishi, et al.
Published: (2001)